Piedāvājumi

Vēl piedāvājumi, lapa 41726

Katram piedāvājumam zemāk ir 13–97% atlaide. Cenas tiek sinhronizētas reāllaikā no pārbaudītiem veikaliem.

HICL Infrastructure PLC (HICL.L): Canvas Business Model
-22%

HICL Infrastructure PLC (HICL.L): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
HICL Infrastructure PLC (HICL.L) DCF Valuation
-40%

HICL Infrastructure PLC (HICL.L) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
HICL Infrastructure PLC (HICL.L): PESTLE Analysis [Dec-2025 Updated]
-22%

HICL Infrastructure PLC (HICL.L): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
HICL Infrastructure PLC (HICL.L): 5 FORCES Analysis [Dec-2025 Updated]
-22%

HICL Infrastructure PLC (HICL.L): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
HICL Infrastructure PLC (HICL.L): VRIO Analysis
-22%

HICL Infrastructure PLC (HICL.L): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
HICL Infrastructure PLC (HICL.L): SWOT Analysis [Dec-2025 Updated]
-22%

HICL Infrastructure PLC (HICL.L): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hikma Pharmaceuticals PLC (HIK.L): Canvas Business Model
-22%

Hikma Pharmaceuticals PLC (HIK.L): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hikma Pharmaceuticals PLC (HIK.L): BCG Matrix [Dec-2025 Updated]
-22%

Hikma Pharmaceuticals PLC (HIK.L): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hikma Pharmaceuticals PLC (HIK.L): Ansoff Matrix
-22%

Hikma Pharmaceuticals PLC (HIK.L): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hikma Pharmaceuticals PLC (HIK.L) DCF Valuation
-40%

Hikma Pharmaceuticals PLC (HIK.L) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Hikma Pharmaceuticals PLC (HIK.L): PESTLE Analysis [Dec-2025 Updated]
-22%

Hikma Pharmaceuticals PLC (HIK.L): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hikma Pharmaceuticals PLC (HIK.L): Marketing Mix Analysis
-22%

Hikma Pharmaceuticals PLC (HIK.L): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hikma Pharmaceuticals PLC (HIK.L): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Hikma Pharmaceuticals PLC (HIK.L): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hikma Pharmaceuticals PLC (HIK.L): SWOT Analysis [Dec-2025 Updated]
-22%

Hikma Pharmaceuticals PLC (HIK.L): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hill & Smith Holdings PLC (HILS.L): Canvas Business Model
-22%

Hill & Smith Holdings PLC (HILS.L): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hill & Smith Holdings PLC (HILS.L): BCG Matrix [Dec-2025 Updated]
-22%

Hill & Smith Holdings PLC (HILS.L): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hill & Smith Holdings PLC (HILS.L): Ansoff Matrix
-22%

Hill & Smith Holdings PLC (HILS.L): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hikma Pharmaceuticals PLC (HIK.L): VRIO Analysis
-22%

Hikma Pharmaceuticals PLC (HIK.L): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hill & Smith Holdings PLC (HILS.L): Marketing Mix Analysis
-22%

Hill & Smith Holdings PLC (HILS.L): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hill & Smith Holdings PLC (HILS.L) DCF Valuation
-40%

Hill & Smith Holdings PLC (HILS.L) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Hill & Smith Holdings PLC (HILS.L): PESTLE Analysis [Dec-2025 Updated]
-22%

Hill & Smith Holdings PLC (HILS.L): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hill & Smith Holdings PLC (HILS.L): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Hill & Smith Holdings PLC (HILS.L): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hill & Smith Holdings PLC (HILS.L): VRIO Analysis
-22%

Hill & Smith Holdings PLC (HILS.L): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Hill & Smith Holdings PLC (HILS.L): SWOT Analysis [Dec-2025 Updated]
-22%

Hill & Smith Holdings PLC (HILS.L): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN